Vertex Pharmaceuticals (VRTX) EPS (Weighted Average and Diluted) Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -25,782.97% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 41.33% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.33% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.99% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 45.47% |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.33% |
| Dec 31, 2025 | 13.90% |
| Sep 30, 2025 | 5.37% |
| Jun 30, 2025 | 8.43% |
| Mar 31, 2025 | -5.60% |
| Dec 31, 2024 | 5.81% |
| Sep 30, 2024 | 6.93% |
| Jun 30, 2024 | -281.53% |
| Mar 31, 2024 | 19.13% |
| Dec 31, 2023 | 17.28% |
| Sep 30, 2023 | 16.20% |
| Jun 30, 2023 | 3.44% |
| Mar 31, 2023 | 5.51% |
| Dec 31, 2022 | 12.08% |
| Sep 30, 2022 | 153.64% |
| Jun 30, 2022 | 44.84% |
| Mar 31, 2022 | 42.17% |
| Dec 31, 2021 | -20.67% |
| Sep 30, 2021 | 87.20% |
| Jun 30, 2021 | -31.25% |
| Mar 31, 2021 | 45.40% |
| Dec 31, 2020 | 80.67% |
| Sep 30, 2020 | 101.41% |
| Jun 30, 2020 | 256.81% |
| Mar 31, 2020 | 32.25% |
| Dec 31, 2019 | 157.90% |
| Sep 30, 2019 | 50.00% |
| Jun 30, 2019 | 81.32% |
| Mar 31, 2019 | 100.49% |
| Dec 31, 2018 | 177.02% |
| Sep 30, 2018 | 48.61% |
| Jun 30, 2018 | 44.63% |
| Mar 31, 2018 | 43.84% |
| Dec 31, 2017 | 36.21% |
| Sep 30, 2017 | 17.11% |
| Jun 30, 2017 | 28.12% |
| Mar 31, 2017 | 44.06% |
| Dec 31, 2016 | -11.88% |
| Sep 30, 2016 | 33.33% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 50.83% |
| Dec 31, 2015 | 3.96% |
| Sep 30, 2015 | -13.04% |
| Jun 30, 2015 | -36.01% |
| Mar 31, 2015 | -57.81% |
| Dec 31, 2014 | -44.22% |
| Sep 30, 2014 | -39.35% |
| Mar 31, 2014 | -4.75% |
| Dec 31, 2013 | 30.28% |
| Sep 30, 2013 | 19.63% |
| Jun 30, 2013 | 36.17% |
| Mar 31, 2013 | -19.88% |
| Dec 31, 2012 | 25.89% |
| Sep 30, 2012 | 31.50% |
| Jun 30, 2012 | 32.09% |
| Mar 31, 2012 | 34.14% |